IDYA vs INBX Stock Comparison
IDYA currently leads INBX in this stock comparison, with AIQ scores of 54 vs 40. The clearest difference is quality.
What is the main difference between IDYA and INBX?
IDYA leads the current stock comparison as IDEAYA Biosciences, Inc., with the clearest separation coming from quality and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
IDEAYA Biosciences, Inc. vs Inhibrx Biosciences Inc.
IDYA leads
IDYA leads by 14 AIQ points, primarily on Quality and Risk Resilience. Wall Street currently favors INBX on target upside.
Stable: 4 of 5 evidence groups support IDYA, and its signal state is cleanly positive.
IDEAYA Biosciences, Inc.
Inhibrx Biosciences Inc.
The Algovestiq AIQ Score currently favors IDYA over INBX, 54 versus 40 as of Nov 15, 2026. IDYA's advantage is driven primarily by stronger quality and risk resilience. IDYA also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors INBX. 4 of 5 covered evidence groups favor IDYA today, and the comparison is rated Stable on stability. IDYA lead: Stable — the AIQ differential has held near 14 points over 30 sessions.
Compare IDEAYA Biosciences, Inc. and Inhibrx Biosciences Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare IDYA and INBX against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Quality51 vs 28IDYA +23
- Risk Resilience61 vs 40IDYA +21
- Momentum63 vs 50IDYA +13
4 of 5 evidence groups favor IDYA. IDYA’s edge is concentrated in quality and risk resilience.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Value +2, not enough on its own to move the overall score.
New signals
- ADX Trend Strengthening — neutral, trend, medium horizon
- MACD Histogram Expanding Bullish — bullish, momentum, short horizon
- OBV Bullish Divergence — bullish, volume, medium horizon (-3.1%)
Largest factor move: Quality -8
No signal started or stopped since the prior session; its 4 active signals are unchanged.
IDYA's lead widened by 2 AIQ points in the latest session.
Deeper signal detail for each name lives on its own signals page — IDYA and INBX both carry a full feed there.
The central trade-off
IDYA (IDEAYA Biosciences, Inc.): the stronger current systematic profile, led by quality and risk resilience.
INBX (Inhibrx Biosciences Inc.): the counter-case, on analyst expectations — but at materially higher volatility, 120.9% against 48.2%.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
IDYAIDYA on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
IDYAIDYA on combined revenue and EPS growth.
Value
EvenThe two are level on Value.
Momentum
IDYAIDYA on the Momentum factor, by 13 points.
Lower downside
IDYAIDYA on Risk Resilience, by 21 points.
Analyst upside
INBXINBX on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors IDYA, analyst targets favor INBX. That disagreement is the most useful thing on this page.
| Measure | IDYA | INBX | Note |
|---|---|---|---|
| Implied upside to target | +53.2% | +194.1% | INBX has more room |
| Target dispersion | +36.9% | 0% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 16 | 4 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
4 of 5 covered evidence groups favor IDYA. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | IDYA | 54 vs 40 |
| Fundamentals | IDYAon balance | TTM ROE -11.5% vs 45.1%; gross margin 100% vs -55%; operating margin -12.7% vs -62.9% — IDYA takes 2 of 3 decided legs, not all of them |
| Valuation | Not covered | Not covered |
| Technicals | IDYA | Price vs 50-day -10.3% vs -12.6%; vs 200-day -6% vs -10.1% |
| Risk Resilience | IDYA | Risk Resilience 61 vs 40 |
| Analyst expectations | INBX | Target upside 53.2% vs 194.1% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of IDYA and INBX and are excluded from the count.
AIQ Decision Stability
The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.
- The AIQ gap is wide at 14 points. (supports the conclusion holding)
- 4 of 5 covered evidence groups point the same way. (supports the conclusion holding)
- The leader's signal state is cleanly positive. (supports the conclusion holding)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on IDYA.
How the comparison changed
120 daily snapshots · May 27 – Nov 13IDYA lead: Stable — the AIQ differential has held near 14 points over 30 sessions.
- Today
- IDYA +14
- 54 vs 40
- 7 sessions ago
- IDYA +17
- 54 vs 37
- 30 sessions ago
- IDYA +13
- 63 vs 50
- 90 sessions ago
- IDYA +23
- 65 vs 42
The lead has not changed hands in this window.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
4 bullish / 0 bearish / 2 neutral
Only IDYA
- ADX Trend Strengthening — neutral, trend, medium horizon
- MACD Histogram Expanding Bullish — bullish, momentum, short horizon
- OBV Bullish Divergence — bullish, volume, medium horizon (-3.1%)
- RSI Bullish Divergence — bullish, momentum, medium horizon
1 bullish / 1 bearish / 2 neutral, conflicted
Only INBX
- ADX Trend Weakening — neutral, trend, medium horizon
- Beta Spike Warning — bearish, risk_regime, long horizon
Both carry 2 more signals that do not separate them: Golden Cross Active, ATR Expansion - Breakout Mode.
INBX is conflicted, so the timing case there is weaker than the score alone suggests.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.08%, AIQ 0 points).
Price and the AIQ Score both moved down over the latest session (price -5.07%, AIQ -2 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1INBX closes the Quality gap — currently 23 points behind, the largest single contributor to IDYA's edge.
- 2INBX's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it.
- 3IDYA's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict.
- 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
IDYA leads on balance| Metric | IDYA | INBX |
|---|---|---|
| Revenue growth (YoY) | 15.6% | 0% |
| EPS growth (YoY) | 0% | -5.1% |
| Gross margin | 100% | -55% |
| Operating margin | -12.7% | -62.9% |
| Return on equity (TTM) | -11.5% | 45.1% |
| Debt to equity | 0.03 | 0 |
Performance
Split across windows| Metric | IDYA | INBX |
|---|---|---|
| 1 week (5 sessions) | 1.9% | -1.4% |
| 1 month (20 sessions) | -3.1% | -7.3% |
| 3 months (63 sessions) | -12.9% | -9.5% |
| 6 months (126 sessions) | 12.8% | -23.3% |
| Year to date | -7.9% | 5.4% |
| 1 year (252 sessions) | -0.4% | 13.6% |
Technicals
IDYA has the stronger structure| Metric | IDYA | INBX |
|---|---|---|
| RSI (14) | 42.4 | 45.1 |
| ADX (14) | 25.8 | 14.2 |
| Price vs 50-day | -10.3% | -12.6% |
| Price vs 200-day | -6% | -10.1% |
| Volatility (1M, annualized) | 48.2% | 120.9% |
Risk
IDYA is the more resilient| Metric | IDYA | INBX |
|---|---|---|
| Beta | 0.94 | 2.18 |
| Sharpe ratio | 0.14 | 0.49 |
| Sortino ratio | 0.2 | 0.76 |
| Max drawdown | -27.8% | -49.4% |
| Current drawdown | -25.1% | -41.3% |
| Annualized volatility | 44.9% | 82.3% |
| Value at risk (95%) | -4.1% | -6.3% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, IDYA or INBX?
On the Algovestiq AIQ Score, IDYA is the stronger of the two as of Nov 15, 2026, scoring 54 against INBX's 40. The edge comes from quality and risk resilience. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is IDYA or INBX the better buy right now?
IDYA carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Stable — 4 of 5 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.
Why does the AIQ Score favor IDYA over INBX?
The composite weights Quality, Value, Momentum and Risk Resilience. IDYA leads Quality by 23 points; IDYA leads Risk Resilience by 21 points; IDYA leads Momentum by 13 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, IDYA or INBX?
Analyst price targets imply +53.2% upside for IDYA and +194.1% for INBX, so the Street currently favors INBX. That points the opposite way to the AIQ Score, which favors IDYA. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, IDYA or INBX?
Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, IDYA or INBX?
IDYA on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, IDYA or INBX?
IDYA on the Momentum factor, by 13 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, IDYA or INBX?
IDYA is the more resilient of the two, so the other name carries the higher downside risk. IDYA on Risk Resilience, by 21 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is IDYA more profitable than INBX?
The profitability evidence is mixed: gross margin 100% vs -55%; operating margin -12.7% vs -62.9%; ttm roe -11.5% vs 45.1%. IDYA leads on two measures and INBX on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.
Is IDYA's lead over INBX getting stronger or weaker?
IDYA lead: Stable — the AIQ differential has held near 14 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.
What would change the IDYA vs INBX verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: INBX closes the Quality gap — currently 23 points behind, the largest single contributor to IDYA's edge; INBX's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it; IDYA's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
What do the current signals say about IDYA and INBX?
IDYA: 4 bullish / 0 bearish / 2 neutral. INBX: 1 bullish / 1 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on IDYA is Golden Cross Active (bullish, long horizon). On INBX it is Golden Cross Active (bullish, long horizon).
Compare IDYA and INBX with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.